ArticleMediterranean journal of hematology and infectious diseases2025
Addition of Daratumumab to First-Line Therapy of Newly Diagnosed Multiple Myeloma in Patients Eligible for Autologous Stem Cell Transplantation: A Single-Center Real-Life Experience.
Edoardo Olivari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.